User Fees

Browse User Fees Content

Now that the House of Representatives and the Senate HELP Committee have passed their respective FDA user fee bills, House and Senate negotiators have been working to conference and reconcile differences in both bills.

Jul 6, 2022

CHPA’s President & CEO, Scott Melville, released a statement in response to the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

May 18, 2022

While this week both the House and Senate are on recess, last week the Senate HELP Committee began the process of meeting to discuss and ultimately pass the Prescription Drug User Fee Act (PDUFA).

Apr 12, 2022

The Senate HELP Committee will vote next Wednesday, January, 12, on whether to send Dr. Robert Califf’s nomination as FDA commissioner to the Senate floor for a confirmation vote.

Jan 5, 2022

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Dec 9, 2021

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Nov 3, 2021

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Aug 4, 2021

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Jul 28, 2021

Just prior to the 4th of July holiday, the House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Appropriations Subcommittee released its FY 2022 Report.

Jul 7, 2021

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Jun 16, 2021

Filter Results